Helix Biotech Biosimilar mRNA Vaccines

A Contract Award Notice
by UK HEALTH SECURITY AGENCY

Source: Find a Tender
Type: Contract ()
Duration: not specified
Value: £150K

Sector: MISCELLANEOUS
Published: 12 Aug 2025
Delivery: not specified
Deadline: n/a

Concepts

Location

Geochart for 1 buyers and 1 suppliers

1 buyer

UK Health Security Agency London

1 supplier

Helix Biotech Knoxville

Description

Vaccine mimic materials-comprising messenger RNA (mRNA) and lipid nanoparticles (LNPs)-from Helix-Biotech.

Award Detail

1	Helix Biotech (Knoxville) Helix Biotech Biosimilar mRNA Vaccines Reference: 1 Value: £150,000

CPV Codes

None found

Legal Justification

Helix-Biotech Inc. is the only supplier capable of delivering the required vaccine mimic materials (mRNA encapsulated in LNPs) with validated equivalence to licensed Pfizer-style COVID-19 vaccines. Their proprietary methodology and formulation capability are not available from other suppliers, nor covered under any current public procurement frameworks.